Best practice in primary care pathology: review 5

This fifth best practice review examines three series of common primary care questions in laboratory medicine: (1) minor liver function test abnormalities; (2) laboratory monitoring of patients receiving lithium; and (3) investigation of possible venous thromboembolism. The review is presented in question–answer format, referenced for each question series. The recommendations represent a precis of guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by Medline Embase searches to identify relevant primary research documents. They are not standards but form a guide to be set in the clinical context. Most are consensus-based rather than evidence-based. They will be updated periodically to take account of new information.

[1]  T. Reynolds,et al.  Best practice in primary care pathology: review 3 , 2006, Journal of Clinical Pathology.

[2]  T. Reynolds,et al.  Best practice in primary care pathology: review 6 , 2006, Journal of Clinical Pathology.

[3]  C. Mcnulty,et al.  Best practice in primary care pathology: review 4 , 2006, Journal of Clinical Pathology.

[4]  C. Mcnulty,et al.  Best practice in primary care pathology: review 2 , 2006, Journal of Clinical Pathology.

[5]  O. Niemelä,et al.  Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. , 2005, Alcohol and alcoholism.

[6]  C. Mcnulty,et al.  Best practice in primary care pathology: review 1 , 2005, Journal of Clinical Pathology.

[7]  Paul Giboney,et al.  Mildly elevated liver transaminase levels in the asymptomatic patient. , 2005, American family physician.

[8]  I. Mackie,et al.  An evaluation of rapid D‐dimer assays for the exclusion of deep vein thrombosis , 2005, British journal of haematology.

[9]  D Freedman,et al.  Methodology for constructing guidance , 2005, Journal of Clinical Pathology.

[10]  Vincenzo Savarino,et al.  Liver enzyme alteration: a guide for clinicians , 2005, Canadian Medical Association Journal.

[11]  J. Windle,et al.  Paget disease of bone. , 2005, The Journal of clinical investigation.

[12]  Richard L. Kravitz,et al.  Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review , 2004, BMJ : British Medical Journal.

[13]  I. Suh,et al.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.

[14]  H. Watson,et al.  The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D‐dimer assays to reduce the need for diagnostic imaging , 2004, British journal of haematology.

[15]  G. Kovacs,et al.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.

[16]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[17]  Swastik Agrawal,et al.  Evaluation of abnormal liver function tests , 2003, Postgraduate medical journal.

[18]  S. Kadakia,et al.  Nonalcoholic steatohepatitis: what we know in the new millennium , 2002, American Journal of Gastroenterology.

[19]  R. Green,et al.  AGA technical review on the evaluation of liver chemistry tests. , 2002, Gastroenterology.

[20]  B. Fitzmaurice,et al.  Monitoring patients on lithium — a good practice guideline , 2002 .

[21]  M. Greaves,et al.  Investigation and management of heritable thrombophilia , 2001, British journal of haematology.

[22]  N. Delva,et al.  Preventing lithium intoxication. Guide for physicians. , 2001, Canadian family physician Medecin de famille canadien.

[23]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[24]  Boland Cr,et al.  American Gastroenterological Association. Our new president--Jon I. Isenberg, M.D. , 2001, Gastroenterology.

[25]  S. Brown,et al.  How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact , 2001, BMJ : British Medical Journal.

[26]  T. Therneau,et al.  An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities , 2000, American Journal of Gastroenterology.

[27]  J. Eagles,et al.  Lithium monitoring before and after the distribution of clinical practice guidelines , 2000, Acta psychiatrica Scandinavica.

[28]  M. Kaplan,et al.  Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.

[29]  Janet A Butler, David Taylor.  A survey of lithium monitoring and prescribing patterns , 2000, International journal of psychiatry in clinical practice.

[30]  T. Ben-Menachem,et al.  Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients , 1999, American Journal of Gastroenterology.

[31]  M. Whitehead,et al.  A prospective study of the causes of notably raised aspartate aminotransferase of liver origin , 1999, Gut.

[32]  D. Kupfer,et al.  Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. , 1999, The American journal of psychiatry.

[33]  R. de Marco,et al.  Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. , 1999, Diabetes care.

[34]  D. Barker,et al.  The epidemiology of Paget's disease of bone. , 1999, British medical bulletin.

[35]  A. Frydén,et al.  The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. , 1999, Scandinavian journal of gastroenterology.

[36]  Bnf,et al.  Using lithium safely , 1999, Drug and therapeutics bulletin.

[37]  G. Minuk,et al.  Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[38]  P. Keck,et al.  Standards of laboratory practice: antidepressant drug monitoring , 1998 .

[39]  J. Aranda‐Michel,et al.  Tests of the liver: use and misuse. , 1998, The Gastroenterologist.

[40]  A. Pakarinen,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.

[41]  L. Balart,et al.  Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. , 1997, The American journal of gastroenterology.

[42]  A. Ryman.  Lithium monitoring in hospital and general practice , 1997 .

[43]  J. De,et al.  Detection of chronic liver disease: costs and benefits. , 1997 .

[44]  A. Caro-Patón.  [Diagnosis of Gilbert's syndrome]. , 1997, Anales de medicina interna.

[45]  J. Rosenbaum,et al.  Serum lithium levels and psychosocial function in patients with bipolar I disorder. , 1996, The American journal of psychiatry.

[46]  R. Theal,et al.  Evaluating asymptomatic patients with abnormal liver function test results. , 1996, American family physician.

[47]  M. Bennett,et al.  The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.

[48]  D Lindhout,et al.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. , 1995, The New England journal of medicine.

[49]  M. Bennett,et al.  Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.

[50]  J. McClellan,et al.  Practice guideline for the treatment of patients with bipolar disorder , 1994 .

[51]  A. B. Prasad,et al.  British National Formulary , 1994 .

[52]  M. E. Ward,et al.  Clinical Pharmacokinetics of Lithium , 1994, Journal of clinical pharmacology.

[53]  N. Sharts‐Hopko.  Lithium and pregnancy. , 1993, MCN. The American journal of maternal child nursing.

[54]  J. Aronson,et al.  ABC of Monitoring Drug Therapy , 1993 .

[55]  R. Hultcrantz,et al.  Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionucleide imaging and liver biopsy , 1993, Journal of internal medicine.

[56]  J. Aronson,et al.  ABC of monitoring drug therapy. Lithium. , 1992, BMJ.

[57]  J. Aronson,et al.  ABC of monitoring drug therapy. Why monitor drug therapy? , 1992, BMJ.

[58]  A. Mander,et al.  Lithium treatment: prescribing and monitoring habits in hospital and general practice. , 1992, BMJ.

[59]  R. Chapman,et al.  Raised gamma-glutamyltransferase activity and the need for liver biopsy. , 1991, BMJ.

[60]  L. Ried,et al.  Therapeutic Drug Monitoring Reduces Toxic Drug Reactions: A Meta‐Analysis , 1990, Therapeutic drug monitoring.

[61]  P. Lavori,et al.  Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. , 1989, The New England journal of medicine.

[62]  J. Ludwig,et al.  The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients , 1989, Hepatology.

[63]  R. Becker,et al.  Serum gamma-glutamyl transpeptidase and chronic alcoholism , 1985, Digestive Diseases and Sciences.

[64]  E. Pauwels,et al.  Untreated Paget disease of bone studied by scintigraphy. , 1984, Radiology.

[65]  A. Emery,et al.  A family study of Paget's disease of bone. , 1983, Journal of epidemiology and community health.

[66]  J. Wilson.  Inherited elevation of alkaline phosphatase activity in the absence of disease. , 1979, The New England journal of medicine.

[67]  A Amdisen,et al.  Serum Level Monitoring and Clinical Pharmacokinetics of Lithium , 1977, Clinical pharmacokinetics.

[68]  H. Watson,et al.  British Committee for Standards in Haematology , 1969 .

[69]  G. Keating,et al.  Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels. , 2005, Drugs.

[70]  Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. , 2004, The Australian and New Zealand journal of psychiatry.

[71]  C. Titcomb.  Liver function tests: what is the risk? , 2003, Journal of insurance medicine.

[72]  G. Gormley,et al.  PSA testing in general practice , 2003, Prostate Cancer and Prostatic Diseases.

[73]  D. Macpherson,et al.  The case against routine preoperative laboratory testing. , 2003, The Medical clinics of North America.

[74]  M. Thase,et al.  Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision) , 2003 .

[75]  J. Kane,et al.  Extending indications for long-term pharmacotherapy: opportunities and challenges. , 2002, The American journal of psychiatry.

[76]  Disciplinary Committee,et al.  Royal Pharmaceutical Society of Great Britain , 2002 .

[77]  American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. , 2002, Gastroenterology.

[78]  N. Delva,et al.  Preventing lithium intoxication , 2001 .

[79]  K. Jamison,et al.  Lithium for maintenance treatment of mood disorders. , 2001, The Cochrane database of systematic reviews.

[80]  C. Cooper,et al.  Epidemiology of Paget's disease of bone. , 1999, Bone.

[81]  M. Goldstein.  Bupropion sustained release and smoking cessation. , 1998, The Journal of clinical psychiatry.

[82]  M. Tueth,et al.  Special considerations: use of lithium in children, adolescents, and elderly populations. , 1998, The Journal of clinical psychiatry.

[83]  P. Keck,et al.  Standards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry. , 1998, Clinical chemistry.

[84]  P. G. Quinn,et al.  Detection of chronic liver disease: costs and benefits. , 1997, The Gastroenterologist.

[85]  Treatment of bipolar disorder. The Expert Consensus Panel for Bipolar Disorder. , 1996, The Journal of clinical psychiatry.

[86]  R. Hultcrantz,et al.  Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. , 1986, Scandinavian journal of gastroenterology.

[87]  K. Ohnishi,et al.  Liver function in moderate obesity--study in 534 moderately obese subjects among 4613 male company employees. , 1986, International journal of obesity.

[88]  Y. Israel,et al.  Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. , 1985, Alcoholism, clinical and experimental research.

[89]  N. Blanckaert,et al.  Serum bilirubins in hepatobiliary disease: Comparison with other liver function tests and changes in the postobstructive period , 1985, Hepatology.

[90]  F. Hardt,et al.  Diagnosis of Gilbert's syndrome. Reliability of the caloric restriction and phenobarbital stimulation tests. , 1981, Scandinavian journal of gastroenterology.

[91]  K. Kusui.  [Liver diseases]. , 1966, Naika. Internal medicine.